Nurix Therapeutics | 4:持股变动声明-高管 van Houte Hans
Nurix Therapeutics | 4:持股变动声明-高管 van Houte Hans
Nurix Therapeutics | 4:持股变动声明-高管 Hansen Gwenn
Nurix Therapeutics | 4:持股变动声明-高管 Ring Christine
Nurix Therapeutics | 4:持股变动声明-高管 van Houte Hans
Nurix Therapeutics | 4:持股变动声明-高管 van Houte Hans
Nurix Therapeutics | 4:持股变动声明-高管 Ring Christine
Nurix Therapeutics | 4:持股变动声明-高管 Hansen Gwenn
Nurix Therapeutics | 4:持股变动声明-高管 SANDS ARTHUR T
Nurix Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Baker Bros. Advisors LP(9.99%),Baker Bros. Advisors (GP) LLC(9.99%)等
Nurix Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Redmile Group, LLC(9.9%),Jeremy C. Green(9.9%)等
Nurix Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-T. ROWE PRICE ASSOCIATES, INC.(4.9%)
Nurix Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)-Deep Track Capital, LP(6.18%),Deep Track Biotechnology Master Fund, Ltd.(6.18%)等
Nurix Therapeutics | SC 13G:超过5%持股股东披露文件-Arthur T. Sands(5.4%)
Nurix Therapeutics | SC 13G:超过5%持股股东披露文件-The Vanguard Group(5.36%)
Nurix Therapeutics | SC 13G/A:超过5%持股股东披露文件(修正)
Nurix Therapeutics | SC 13G:超过5%持股股东披露文件-Morgan Stanley(6.4%)
Nurix Therapeutics | 4:持股变动声明-高管 van Houte Hans
Nurix Therapeutics | 4:持股变动声明-高管 Hansen Gwenn
Nurix Therapeutics | 4:持股变动声明-高管 Ring Christine
暂无数据